CdcA Antibodies

Santa Cruz Biotechnology features a diverse variety of CdcA Antibodies for research in cell cycle regulation and cancer biology. CdcA Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CdcA, or Cell Division Cycle Associated protein A, plays a crucial role in the regulation of the cell cycle, particularly in the transition from G1 to S phase. Proper CdcA function is essential for maintaining cellular proliferation and ensuring genomic stability. Dysregulation of CdcA has been implicated in various cancers, making it a significant target for therapeutic intervention and biomarker discovery. Understanding CdcA's role in cell cycle control can provide valuable insights into cancer development and progression. Investigating CdcA expression patterns helps reveal mechanisms underlying cellular division and growth regulation. Exploring CdcA interactions with other cell cycle proteins advances knowledge of regulatory networks. Santa Cruz Biotechnology monoclonal antibodies for CdcA research support scientists worldwide in advancing cancer biology and cell cycle studies.